{"id":"https://openalex.org/W3021533592","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2040","title":"Phase 1 trial of oral MAC-321 in subjects with advanced malignant solid tumors","display_name":"Phase 1 trial of oral MAC-321 in subjects with advanced malignant solid tumors","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W3021533592","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2040","mag":"3021533592"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.2040","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2040","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.2040","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034879909","display_name":"Andrew X. Zhu","orcid":"https://orcid.org/0000-0001-7495-1528","observed_orcids":["https://orcid.org/0000-0001-7495-1528"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. X. Zhu","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055433665","display_name":"Ronald Bukowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Bukowski","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064343766","display_name":"Albert Craig Lockhart","orcid":"https://orcid.org/0000-0003-1256-6709","observed_orcids":["https://orcid.org/0000-0003-1256-6709"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. C. Lockhart","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025078826","display_name":"K. K. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. K. Wang","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016276005","display_name":"Wendy Cooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Cooper","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109515111","display_name":"Jeffrey Grover","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Grover","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Cohen","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012316179","display_name":"Leonard Joseph Appleman","orcid":"https://orcid.org/0000-0003-4951-7388","observed_orcids":["https://orcid.org/0000-0003-4951-7388"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Appleman","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065909945","display_name":"MICHAEL E. SHAPIRO","orcid":"https://orcid.org/0000-0001-7491-6490","observed_orcids":["https://orcid.org/0000-0001-7491-6490"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Shapiro","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109982877","display_name":"Mace L. Rothenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. L. Rothenberg","raw_affiliation_strings":["Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Partners CancerCare, Boston, MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH; Vanderbilt University Medical Center, Nashville, TN; Wyeth Research, Cambridge, MA; Taxolog Inc, Fairfield, NJ","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"2040","last_page":"2040"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel-resistance","display_name":"paclitaxel resistance","score":0.7720000147819519},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9279999732971191},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7620000243186951},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9120000004768372},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7020000219345093},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.6119999885559082},{"id":"https://openalex.org/keywords/mesothelioma","display_name":"mesothelioma","score":0.8820000290870667},{"id":"https://openalex.org/keywords/chondrosarcoma","display_name":"chondrosarcoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/small-cell-carcinoma","display_name":"small cell carcinoma","score":0.9350000023841858},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9480000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9291912317276001},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7485204935073853},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.6975451707839966},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6307364702224731},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5817582011222839},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5405493974685669},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4469180703163147},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.417649507522583},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.41578003764152527},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4056641757488251},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3971785008907318},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36259111762046814},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.36180615425109863},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.19933372735977173}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.2040","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2040","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.2040","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.2040","doi":"https://doi.org/10.1200/jco.2004.22.90140.2040","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.2040","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1995811281","https://openalex.org/W2533990779","https://openalex.org/W2226053969","https://openalex.org/W2898133907","https://openalex.org/W1897524963","https://openalex.org/W2051905300","https://openalex.org/W2264253913","https://openalex.org/W2238291514","https://openalex.org/W2080968500","https://openalex.org/W2244116267"],"abstract_inverted_index":{"2040":[0],"Background:":[1],"MAC-321":[2,24,51,61,219,249],"is":[3,279],"a":[4,238,261],"novel":[5],"taxane":[6],"that":[7],"has":[8],"demonstrated":[9],"exceptional":[10],"activity":[11,28,59],"in":[12,29,187,215,237],"human":[13],"xenograft":[14],"models":[15],"when":[16],"administered":[17,50,253],"intravenously":[18],"and":[19,31,46,81,85,179,205,232,290],"orally.":[20],"Preclinical":[21],"studies":[22],"of":[23,48,60,98,167,263,296],"have":[25],"shown":[26],"antitumor":[27,58],"MDR-expressing":[30],"paclitaxel-resistant":[32],"tumors.":[33],"Methods:":[34],"This":[35,277],"phase":[36],"1":[37,228],"ascending-dose":[38],"study":[39,278],"was":[40,62,92,120,185,211,220,269],"performed":[41,93],"to":[42,116,260,281,291],"determine":[43,292],"the":[44,95,124,191,216,286,293],"safety":[45],"tolerability":[47],"orally":[49,254],"given":[52],"once":[53,255],"every":[54,256],"21":[55,257],"days.":[56],"Preliminary":[57],"also":[63],"examined.":[64],"Key":[65],"eligibility":[66],"criteria":[67],"included":[68,175],"adult":[69],"patients":[70,102,134,159,189,273],"with":[71,144,148,156,190,223],"refractory":[72],"solid":[73],"tumors,":[74],"good":[75],"performance":[76],"status":[77],"(ECOG":[78],"\u2264":[79],"2),":[80],"adequate":[82],"hematologic,":[83],"hepatic,":[84],"renal":[86],"function.":[87],"Plasma":[88],"pharmacokinetic":[89],"(PK)":[90],"sampling":[91],"during":[94],"first":[96,125],"cycle":[97],"therapy.":[99],"Results:":[100],"18":[101],"(4":[103],"females,":[104],"14":[105],"males)":[106],"were":[107,160],"evaluated":[108],"at":[109,123,139,162],"5":[110],"dose":[111,127,165,262,289],"levels":[112,128],"ranging":[113],"from":[114,245],"25":[115],"75":[117,140],"mg/m2.":[118,265],"Treatment":[119],"well":[121],"tolerated":[122,288],"3":[126,146],"(25,":[129],"37,":[130],"50":[131],"mg/m2).":[132],"Two":[133],"developed":[135],"dose-limiting":[136],"toxicities":[137,174],"(DLTs)":[138],"mg/m2":[141,169,284],"(1":[142],"patient":[143,151],"grade":[145,153,176,180],"neutropenia":[147,155],"fever,":[149],"another":[150],"had":[152,274],"4":[154,188],"fever).":[157],"Three":[158],"treated":[161],"an":[163],"intermediate":[164],"level":[166],"60":[168,264,283],"without":[170],"DLTs.":[171],"Other":[172,313],"common":[173],"1\u20132":[177,181],"fatigue":[178],"diarrhea.":[182],"Disease":[183],"stabilization":[184],"seen":[186],"following":[192],"tumors:":[193],"mesothelioma":[194],"(14":[195],"cycles),":[196,199,204],"chondrosarcoma":[197],"(12":[198],"small":[200],"cell":[201],"carcinoma":[202,207],"(10":[203],"prostate":[206],"(6":[208],"cycles).":[209],"There":[210],"substantial":[212],"interpatient":[213],"variability":[214],"PK":[217],"parameters.":[218],"absorbed":[221],"rapidly":[222],"mean":[224],"Tmax":[225],"less":[226],"than":[227],"hour.":[229],"Mean":[230],"Cmax":[231],"AUC":[233],"values":[234],"generally":[235],"increased":[236],"dose-related":[239],"manner.":[240],"The":[241,266],"elimination":[242],"half-life":[243],"ranged":[244],"20\u2013228":[246],"hours.":[247],"Conclusions:":[248],"can":[250],"be":[251],"safely":[252],"days":[258],"up":[259],"major":[267],"DLT":[268],"neutropenic":[270],"fever.":[271],"Four":[272],"disease":[275],"stabilization.":[276],"ongoing":[280],"confirm":[282],"as":[285],"maximum":[287],"oral":[294],"bioavailability":[295],"MAC-321.":[297],"Author":[298],"Disclosure":[299],"Employment":[300],"or":[301,304],"Leadership":[302],"Consultant":[303],"Advisory":[305],"Stock":[306],"Ownership":[307],"Honoraria":[308],"Research":[309],"Funding":[310],"Expert":[311],"Testimony":[312],"Remuneration":[314],"Taxolog,":[315],"Inc.;":[316],"Wyeth":[317]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2020-05-13T00:00:00"}